Your browser doesn't support javascript.
loading
Progress of tolvaptan in treating heart failure / 中华老年医学杂志
Chinese Journal of Geriatrics ; (12): 214-216, 2016.
Artículo en Chino | WPRIM | ID: wpr-494213
ABSTRACT
Tolvaptan is a novel oral selective arginine vasopressin V2 receptor antagonist.Tolvaptan improves heart failure signs and symptoms without serious adverse events.Tolvaptan has no effect on all-cause mortality and cardiovascular death or admission rate for heart failure.But in heart failure patients with hyponatremia,tolvaptan can decrease cardiovascular death and admission rate for heart failure.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Journal of Geriatrics Año: 2016 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Journal of Geriatrics Año: 2016 Tipo del documento: Artículo